3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
5
Genitourinary
1
Endocrine
1
Conditions
Prostatic Neoplasms
1106
Carcinoma, Renal Cell
412
Urinary Bladder Neoplasms
280
Kidney Neoplasms
177
Neoplasm Metastasis
134
Neoplasms
132
Carcinoma, Non-Small-Cell Lung
109
Carcinoma, Transitional Cell
108
Breast Neoplasms
94
Melanoma
90
Ovarian Neoplasms
70
Lung Neoplasms
67
Colorectal Neoplasms
58
Pancreatic Neoplasms
49
Sarcoma
48
Wilms Tumor
41
Uterine Cervical Neoplasms
37
Head and Neck Neoplasms
37
Stomach Neoplasms
36
Testicular Neoplasms
33
Non-Muscle Invasive Bladder Neoplasms
33
Esophageal Neoplasms
33
Squamous Cell Carcinoma of Head and Neck
31
Neuroblastoma
30
Lymphoma, Non-Hodgkin
29
Colonic Neoplasms
28
Small Cell Lung Carcinoma
27
Carcinoma, Hepatocellular
27
Urethral Neoplasms
25
Triple Negative Breast Neoplasms
23
Interventions
etelcalcetide hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Hyperparathyroidism
×
Genitourinary
×
Clear all
NCT03960437
2023-09-21
Parsabiv-MBD
Columbia University
Phase 2
Completed
22 enrolled
14 charts